2012

Capital Royalty Provides Financing to Bioniche Life Sciences

Effective April 10, 2012, Capital Royalty Partners II, entered into a $20 million term loan and revenue interest financing agreement with Bioniche Life Sciences, a research-based, technology-driven Canadian biopharmaceutical company. Under the terms of the agreement, Capital Royalty provided Bioniche a five-year $20 million loan, with proceeds from the financing intended to support corporate growth initiatives across Bioniche’s three primary business units – Human Health, Animal Health, and Food Safety.